Cargando…
No Cytotoxic and Inflammatory Effects of Empagliflozin and Dapagliflozin on Primary Renal Proximal Tubular Epithelial Cells under Diabetic Conditions In Vitro
Gliflozins are inhibitors of the renal proximal tubular sodium-glucose co-transporter-2 (SGLT-2), that inhibit reabsorption of urinary glucose and they are able to reduce hyperglycemia in patients with type 2 diabetes. A renoprotective function of gliflozins has been proven in diabetic nephropathy,...
Autores principales: | Baer, Patrick C., Koch, Benjamin, Freitag, Janina, Schubert, Ralf, Geiger, Helmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013746/ https://www.ncbi.nlm.nih.gov/pubmed/31936266 http://dx.doi.org/10.3390/ijms21020391 |
Ejemplares similares
-
Gliflozins Have an Anti-Inflammatory Effect on Renal Proximal Tubular Epithelial Cells in a Diabetic and Inflammatory Microenvironment In Vitro
por: Koch, Benjamin, et al.
Publicado: (2023) -
microRNA Expression of Renal Proximal Tubular Epithelial Cells and Their Extracellular Vesicles in an Inflammatory Microenvironment In Vitro
por: Baer, Patrick C., et al.
Publicado: (2023) -
Proximal tubular epithelia-specific transcriptomics of diabetic mice treated with dapagliflozin
por: Uehara-Watanabe, Noriko, et al.
Publicado: (2022) -
Dapagliflozin Prevents High-Glucose-Induced Cellular Senescence in Renal Tubular Epithelial Cells
por: Eleftheriadis, Theodoros, et al.
Publicado: (2022) -
Dapagliflozin versus empagliflozin in patients with chronic kidney disease
por: Alnsasra, Hilmi, et al.
Publicado: (2023)